Tone mix
Week by week 52 weeks
Share of Iovance Biotherapeutics, Inc. Common Stock's 163 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jun 1, 2026 · tone +100Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001+73
- Week of Mar 2, 2026 · tone +100Iovance Biotherapeutics (IOVA) Reports 61% Annual Revenue Growth Driven by Amtagvi Success+63
- Week of May 11, 2026 · tone -29Chardan Cuts Iovance (IOVA) Price Target, Keeps Buy Rating-63
- Week of Aug 31, 2026 · tone 0Iovance Biotherapeutics to Present at Upcoming Conferences-51
- Week of Aug 24, 2026 · tone 0292,962 Shares in Iovance Biotherapeutics, Inc. $IOVA Bought by Ieq Capital LLC-49
- Week of Jul 20, 2026 · tone 0Iovance Biotherapeutics Sees Unusually Large Options Volume (NASDAQ:IOVA)-49
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Iovance Biotherapeutics, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 5 | 0 |
| Last 30 sessions | 28 | +42 |
| Last 90 sessions | 61 | +45 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, October 29, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletIovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precision Medicine StrategyNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precision Medicine Strategy | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 27, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletIovance Biotherapeutics to Report Third Quarter 2026 Financial Results and Corporate Updates on Thursday, November 5, 2026Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Iovance Biotherapeutics to Report Third Quarter 2026 Financial Results and Corporate Updates on Thursday, November 5, 2026 | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletIovance Biotherapeutics (NASDAQ:IOVA) & CAMP4 Therapeutics (NASDAQ:CAMP) Head-To-Head AnalysisNeutral
- www.tickerreport.com · 1 outletCritical Analysis: Iovance Biotherapeutics (NASDAQ:IOVA) vs. CAMP4 Therapeutics (NASDAQ:CAMP)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Iovance Biotherapeutics (NASDAQ:IOVA) & CAMP4 Therapeutics (NASDAQ:CAMP) Head-To-Head Analysis | www.dailypolitical.com | 1 | Neutral |
| Critical Analysis: Iovance Biotherapeutics (NASDAQ:IOVA) vs. CAMP4 Therapeutics (NASDAQ:CAMP) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletFinancial Analysis: MannKind (NASDAQ:MNKD) & Iovance Biotherapeutics (NASDAQ:IOVA)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Financial Analysis: MannKind (NASDAQ:MNKD) & Iovance Biotherapeutics (NASDAQ:IOVA) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- seekingalpha.com · 1 outletUndercovered Stocks: Hess Midstream, Iovance Biotherapeutics, Netlist, And MoreNeutral
- www.manilatimes.net · 1 outletIovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Undercovered Stocks: Hess Midstream, Iovance Biotherapeutics, Netlist, And More | seekingalpha.com | 1 | Neutral |
| Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Iovance Biotherapeutics, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.